Literature DB >> 24468577

Relationships between sleep and addiction: the role of drug-environment conditioning.

Laís F Berro1, Roberto Frussa-Filho2, Sergio Tufik3, Monica L Andersen4.   

Abstract

Addiction to cocaine and other amphetamine-like psychostimulants is a chronic relapsing disorder characterized by loss of control over drug taking. Sleep disturbance is common among patients in recovery from drug abuse and can precipitate relapse. It has been widely demonstrated that sleep deprivation and psychostimulants share similar neurobiological effects regarding the dopaminergic system. In addition, the persistence of a drug-environment conditioning induced by repeated psychostimulant treatment, which is deeply related to the dopaminergic neurotransmission, is thought to play a key role in the addictive cycle. In this scenario, we hypothesized that sleep deprivation is a potential detrimental factor to the extinction process of previously established drug-environment conditioning. Therefore, sleep deprivation would extend the pairing between the cocaine reinforcing effects and the environmental cues, thereby leading drug abusers to relapse.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 24468577     DOI: 10.1016/j.mehy.2013.12.026

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  4 in total

1.  Sleep time differs among people who co-use cocaine and cannabis compared to people who only use cocaine.

Authors:  Paris B Wheeler; Jardin N Dogan; Danelle Stevens-Watkins; William W Stoops
Journal:  Pharmacol Biochem Behav       Date:  2021-01-13       Impact factor: 3.533

Review 2.  At the intersection of sleep deficiency and opioid use: mechanisms and therapeutic opportunities.

Authors:  Mark K Greenwald; Tabitha E H Moses; Timothy A Roehrs
Journal:  Transl Res       Date:  2021-03-09       Impact factor: 10.171

3.  Reduced sleep duration mediates decreases in striatal D2/D3 receptor availability in cocaine abusers.

Authors:  C E Wiers; E Shumay; E Cabrera; E Shokri-Kojori; T E Gladwin; E Skarda; S I Cunningham; S W Kim; T C Wong; D Tomasi; G-J Wang; N D Volkow
Journal:  Transl Psychiatry       Date:  2016-03-08       Impact factor: 6.222

Review 4.  Molecular Imaging of Opioid and Dopamine Systems: Insights Into the Pharmacogenetics of Opioid Use Disorders.

Authors:  Jamie A Burns; Danielle S Kroll; Dana E Feldman; Christopher Kure Liu; Peter Manza; Corinde E Wiers; Nora D Volkow; Gene-Jack Wang
Journal:  Front Psychiatry       Date:  2019-09-18       Impact factor: 4.157

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.